Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Comoros Technology Digest.
Press releases published on June 12, 2025

Odysight.ai to Participate in the 15th Annual ROTH London Conference on June 25 and 26
Omer, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (Nasdaq: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions, today announced it will participate in the 15th Annual ROTH …

Inuvo Reaffirms 25% Q2 YOY Growth Guidance and Completes 1:10 Reverse Stock Split
LITTLE ROCK, Ark., June 12, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence-driven AdTech solutions, today announced that it was reaffirming its prior guidance that the Company was expecting revenue …

ZenaTech’s ZenaDrone to File Patent and Accelerate Deployment of Counter-UAS Technology on the ZenaDrone 1000 in Response to US Executive Order
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and …

Fiduciary Services Group Selects Midaxo to Drive Programmatic M&A Strategy
BOSTON and PHILADELPHIA, June 12, 2025 (GLOBE NEWSWIRE) -- Fiduciary Services Group (FSG), a forward-thinking retirement services firm, has selected Midaxo, a leading mergers and acquisitions (M…

NordPass aims to solve the password sharing mess in companies with a new feature
LONDON, June 12, 2025 (GLOBE NEWSWIRE) -- NordPass, a password manager and innovator of seamless authentication solutions, has introduced a unique, user-friendly dashboard that gives businesses control over all their shared credentials and folders. This …

Werewolf Therapeutics to Participate in the BIO International Convention
WATERTOWN, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …

BairesDev Ranked Among Clutch’s Top Software Leaders 2025 with Triple Recognition
MOUNTAIN VIEW, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- BairesDev®, an award-winning nearshore software development company, has been recognized with three 2025 Clutch Awards, highlighting its performance and reliability in software development across key …

Rackspace Study Reveals AI Leaders Are Scaling Agents at 3x the Rate of Their Peers
SAN ANTONIO, TX, June 12, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology (NASDAQ: RXT), a leading hybrid cloud and AI solutions company, today released a global report, The AI Acceleration Gap: Why Some Enterprises are Surging Ahead, revealing a widening …

BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients
GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the …

Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension
Key complex product approval in the Affordable Medicines segment this year Commercial launch planned for third quarter of 2025 BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the …

CLEAR and Greenhouse Announce Partnership to Enable Candidate Verification
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity company, today announced a new partnership with Greenhouse, trusted HR tech leader and hiring platform, to implement CLEAR1, the identity platform for businesses, to improve …

illumin Announces Voting Results of Annual Meeting of Shareholders
TORONTO and NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX:ILLM, OTCQB:ILLMF) (“illumin” or “Corporation”), the advertising technology platform that enables you to win your next customer, today announced that at its annual general …

Angitia Biopharmaceuticals Announces Topline Results from First in Human Study of AGA2115, A Bispecific Antibody for the Treatment of Osteogenesis Imperfecta
WESTLAKE VILLAGE, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases, today announced topline …

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress
– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1-m and KMT2A-r AML – – 93% (41/44) and 89% (24/27) CRc observed in NPM1-m and …

New Wave Announces Proposed Name Change and Reiterates Its Investment Policy
Vancouver, BC, June 12, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it is proposing a name change and reiterates its Investment Policy and strategic focus. …

Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
CHASKA, Minn., June 12, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has received the remaining $10 million in …

Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Waldenström…
Complete response achieved in CLL; overall objective response rate of 80.9% in CLL patients and 84.2% in patients with WM Bexobrutideg was well tolerated with no new safety signals observed with longer duration on study or higher doses Data reinforces …

Rumble Names Ben Torres Ezrick, Former Marketing Leader with Zoom and Google, as First-Ever CMO
LONGBOAT KEY, Fla., June 12, 2025 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today named its first-ever Chief Marketing Officer, Ben Torres Ezrick, a marketing leader with a career spanning the tech, …

Nuveen Selects Molecule Software’s ETRM to Scale Renewable Trading Capabilities
HOUSTON, June 12, 2025 (GLOBE NEWSWIRE) -- Molecule Software is today announcing that global investment leader Nuveen, a TIAA company, has selected Molecule’s future-ready ETRM software to accelerate its expanding renewable power trading operations. Nuveen …

American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System's Breakthrough Results in Ventilator Weaning
EXTON, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical, Inc., a pioneering medical device company focused on neurostimulation therapies for critical care patients, today announced the publication of pivotal clinical trial results in the American …